Daxxify

Daxxify (daxibotulinumtoxinA-lanm) is a breakthrough neuromodulator developed by Revance Therapeutics. While it is often compared to Botox, it represents a significant technological leap in the world of “wrinkle relaxers.”

Key Product Features

• The “Peptide” Difference: Unlike Botox, Dysport, or Xeomin, which use human serum albumin (a blood-derived protein) as a stabilizer, Daxxify is the first and only neuromodulator stabilized with Peptide Exchange Technology™ (PXT). It is entirely free of human or animal by-products.

• Unmatched Longevity: The most significant advantage of Daxxify is how long it lasts. While traditional neurotoxins typically wear off after 3–4 months, Daxxify is FDA-approved to last an average of 6 months, with some patients seeing results for up to 9 months.

• Fast Onset: Many patients report seeing the effects of Daxxify very quickly, often within 24 to 48 hours after injection.

• Premium “Glow”: Due to its unique peptide formulation, users often describe a specific “Daxxify glow”—a smooth, polished appearance of the skin that goes beyond just muscle relaxation.

Primary Applications

• Glabellar Lines: It is primarily FDA-approved for the temporary improvement of moderate to severe frown lines (the “11” lines between the eyebrows).

• Off-Label Uses: Similar to other toxins, it is widely used by specialists for forehead lines, crow’s feet, and “liquid lip flips.”